Agile Therapeutics Message Board

What's the Strategy in the U.S. for Neovasc's Reducer?

2 days ago

Neovasc (Nasdaq: NVCN) is a medical device company primarily known for Reducer, which is a minimally invasive device that helps treat patients with refractory angina. The device has been approved in Europe

Twirla is ready for approval on Nov 16th

2 months ago

I don't know...look at the price action on the stock the last three days. Started the week around 2.05 and now at 2.46. Maybe someone knows something about approval soon.